A Clinical Study of the Safety and Effectiveness of an Investigational Cell Therapy Given With and Without an Investigational RNA-based Vaccine in Patients With Organ Tumors
BioNTech SE
BioNTech SE
Eli Lilly and Company
Kivu Bioscience Inc.
Kestrel Therapeutics, Inc.
National Cancer Institute (NCI)
OncoC4, Inc.
Revolution Medicines, Inc.
USWM, LLC (dba US WorldMeds)
Fate Therapeutics
IDEAYA Biosciences
Agenus Inc.
Radiopharm Theranostics, Ltd
Whitehawk Therapeutics, Inc.
GlaxoSmithKline
SystImmune Inc.
Institut Paoli-Calmettes
Eli Lilly and Company
AstraZeneca
BeOne Medicines
Seagen Inc.
Myeloid Therapeutics
Tizona Therapeutics, Inc
NiKang Therapeutics, Inc.
MacroGenics
SystImmune Inc.
Pheon Therapeutics
Eli Lilly and Company
Seagen Inc.
Dren Bio
Sairopa B.V.
NextCure, Inc.
NeoTX Therapeutics Ltd.
West China Hospital
SystImmune Inc.
Incyte Corporation
NiKang Therapeutics, Inc.
Tempest Therapeutics
Pfizer
Exelixis
Numab Therapeutics AG
Lyell Immunopharma, Inc.
NextPoint Therapeutics, Inc.
Black Diamond Therapeutics, Inc.
Theratechnologies
Exelixis
Inspirna, Inc.
Seagen Inc.
Seagen Inc.
Checkpoint Therapeutics, Inc.
Compugen Ltd